SOPHiA GENETICS SA (SOPH) · Insider trading
What SOPHiA GENETICS's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$99,000
1 insider, 1 trade
Sold, 12 months
$5.18M
10 insiders, 99% under a plan
Net, 12 months
−$5.08M
bought less sold
Latest filing
2026-10-14
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Camblong JurgiDirector, Executive Chairman | – | $2.73M | 34 | 2026-10-12 | 3,387,150 |
| Xu ZhenyuChief Scientific Officer | – | $814,029 | 27 | 2026-10-13 | 541,493 |
| Menu PhilippeChief Medical Officer | – | $538,879 | 24 | 2026-10-12 | 195,993 |
| Verma AbhimanyuChief Technology Officer | – | $283,152 | 9 | 2026-10-05 | 166,887 |
| Muken RossDirector, Chief Executive Officer | – | $249,741 | 14 | 2026-10-05 | 660,391 |
| Valente ManuelaChief People Officer | – | $183,562 | 9 | 2026-10-05 | 206,210 |
| Van Well DaanChief Legal Officer | – | $166,483 | 10 | 2026-10-05 | 332,716 |
| Cardoza GeorgeChief Financial Officer | $99,000 | $66,440 | 9 | 2026-10-05 | 306,726 |
| Hibbs Kathy LDirector | – | $140,125 | 3 | 2026-09-08 | 96,992 |
| Puylaert KevinChief Sales Officer | – | $6,345 | 12 | 2026-10-05 | 147,763 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-13 | Xu ZhenyuChief Scientific Officer | Saleplan | 4,000 | 7.18 | $28,727 | 541,493 | Form 4 |
| 2026-10-12 | Camblong JurgiDirector, Executive Chairman | Saleplan | 8,500 | 7.26 | $61,671 | 3,387,150 | Form 4 |
| 2026-10-12 | Menu PhilippeChief Medical Officer | Saleplan | 5,000 | 7.26 | $36,303 | 195,993 | Form 4 |
| 2026-10-05 | Muken RossDirector, Chief Executive Officer | Saleplan | 9,838 | 8.13 | $79,971 | 660,391 | Form 4 |
| 2026-10-05 | Xu ZhenyuChief Scientific Officer | Saleplan | 7,394 | 8.12 | $60,075 | 545,493 | Form 4 |
| 2026-10-05 | Camblong JurgiDirector, Executive Chairman | Saleplan | 40,172 | 8.13 | $326,526 | 3,395,650 | Form 4 |
| 2026-10-05 | Menu PhilippeChief Medical Officer | Saleplan | 7,394 | 8.13 | $60,100 | 200,993 | Form 4 |
| 2026-10-05 | Cardoza GeorgeChief Financial Officer | Saleplan | 1,592 | 8.10 | $12,897 | 306,726 | Form 4 |
| 2026-10-05 | Puylaert KevinChief Sales Officer | Sale | 185 | 8.06 | $1,491 | 147,763 | Form 4 |
| 2026-10-05 | Puylaert KevinChief Sales Officer | Sale | 31 | 7.92 | $246 | 147,732 | Form 4 |
| 2026-10-05 | Verma AbhimanyuChief Technology Officer | Saleplan | 5,284 | 8.12 | $42,929 | 166,887 | Form 4 |
| 2026-10-05 | Valente ManuelaChief People Officer | Saleplan | 4,240 | 8.13 | $34,487 | 206,210 | Form 4 |
| 2026-10-05 | Van Well DaanChief Legal Officer | Saleplan | 6,168 | 8.12 | $50,100 | 332,716 | Form 4 |
| 2026-09-21 | Muken RossDirector, Chief Executive Officer | Saleplan | 422 | 8.33 | $3,515 | 670,229 | Form 4 |
| 2026-09-21 | Cardoza GeorgeChief Financial Officer | Saleplan | 774 | 8.33 | $6,447 | 308,318 | Form 4 |
| 2026-09-14 | Xu ZhenyuChief Scientific Officer | Saleplan | 4,000 | 7.88 | $31,520 | 552,887 | Form 4 |
| 2026-09-14 | Menu PhilippeChief Medical Officer | Sale | 5,000 | 7.88 | $39,400 | 208,387 | Form 4 |
| 2026-09-11 | Van Well DaanChief Legal Officer | Saleplan | 6,168 | 7.63 | $47,062 | 338,884 | Form 4 |
| 2026-09-10 | Camblong JurgiDirector, Executive Chairman | Saleplan | 8,500 | 7.66 | $65,110 | 3,435,822 | Form 4 |
| 2026-09-08 | Hibbs Kathy LDirector | Saleplan | 6,250 | 8.13 | $50,813 | 96,992 | Form 4 |
| 2026-08-27 | Xu ZhenyuChief Scientific Officer | Saleplan | 10,000 | 8.91 | $89,100 | 556,887 | Form 4 |
| 2026-08-25 | Hibbs Kathy LDirector | Saleplan | 6,250 | 8.68 | $54,250 | 103,242 | Form 4 |
| 2026-08-25 | Menu PhilippeChief Medical Officer | Saleplan | 5,000 | 8.68 | $43,400 | 213,387 | Form 4 |
| 2026-08-24 | Verma AbhimanyuChief Technology Officer | Saleplan | 5,000 | 8.80 | $44,000 | 172,171 | Form 4 |
| 2026-08-21 | Xu ZhenyuChief Scientific Officer | Saleplan | 5,408 | 8.40 | $45,427 | 566,887 | Form 4 |
| 2026-08-20 | Xu ZhenyuChief Scientific Officer | Saleplan | 4,592 | 8.41 | $38,619 | 572,295 | Form 4 |
| 2026-08-19 | Verma AbhimanyuChief Technology Officer | Saleplan | 5,000 | 8.20 | $41,000 | 177,171 | Form 4 |
| 2026-08-19 | Xu ZhenyuChief Scientific Officer | Saleplan | 10,000 | 7.94 | $79,400 | 576,887 | Form 4 |
| 2026-08-19 | Valente ManuelaChief People Officer | Saleplan | 10,000 | 7.94 | $79,400 | 210,450 | Form 4 |
| 2026-08-13 | Xu ZhenyuChief Scientific Officer | Saleplan | 4,000 | 7.52 | $30,080 | 586,887 | Form 4 |
| 2026-08-12 | Menu PhilippeChief Medical Officer | Saleplan | 5,000 | 7.52 | $37,600 | 218,387 | Form 4 |
| 2026-08-10 | Camblong JurgiDirector, Executive Chairman | Saleplan | 8,500 | 7.61 | $64,685 | 3,444,322 | Form 4 |
| 2026-08-07 | Camblong JurgiDirector, Executive Chairman | Saleplan | 20,000 | 7.23 | $144,600 | 3,452,822 | Form 4 |
| 2026-08-07 | Verma AbhimanyuChief Technology Officer | Saleplan | 5,000 | 7.60 | $38,000 | 182,171 | Form 4 |
| 2026-08-07 | Xu ZhenyuChief Scientific Officer | Saleplan | 7,000 | 7.02 | $49,140 | 600,887 | Form 4 |
| 2026-08-07 | Xu ZhenyuChief Scientific Officer | Saleplan | 10,000 | 7.48 | $74,800 | 590,887 | Form 4 |
| 2026-08-05 | Xu ZhenyuChief Scientific Officer | Saleplan | 3,000 | 7.00 | $21,000 | 600,887 | Form 4 |
| 2026-08-04 | Xu ZhenyuChief Scientific Officer | Saleplan | 10,000 | 6.92 | $69,200 | 600,887 | Form 4 |
| 2026-08-04 | Camblong JurgiDirector, Executive Chairman | Saleplan | 20,000 | 6.92 | $138,400 | 3,472,822 | Form 4 |
| 2026-08-04 | Verma AbhimanyuChief Technology Officer | Saleplan | 5,000 | 6.95 | $34,750 | 187,171 | Form 4 |
111 more
| 2026-07-27 | Menu PhilippeChief Medical Officer | Saleplan | 5,000 | 5.66 | $28,300 | 223,387 | Form 4 |
| 2026-07-21 | Camblong JurgiDirector, Executive Chairman | Saleplan | 20,000 | 6.63 | $132,600 | 3,492,822 | Form 4 |
| 2026-07-20 | Camblong JurgiDirector, Executive Chairman | Saleplan | 19,800 | 6.32 | $125,136 | 3,512,822 | Form 4 |
| 2026-07-20 | Camblong JurgiDirector, Executive Chairman | Saleplan | 4,581 | 6.17 | $28,265 | 3,512,822 | Form 4 |
| 2026-07-13 | Xu ZhenyuChief Scientific Officer | Saleplan | 4,000 | 5.70 | $22,800 | 610,887 | Form 4 |
| 2026-07-13 | Menu PhilippeChief Medical Officer | Saleplan | 5,000 | 5.70 | $28,500 | 228,387 | Form 4 |
| 2026-07-10 | Camblong JurgiDirector, Executive Chairman | Saleplan | 8,500 | 5.62 | $47,770 | 3,532,622 | Form 4 |
| 2026-07-07 | Camblong JurgiDirector, Executive Chairman | Saleplan | 17,685 | 5.28 | $93,377 | 3,541,122 | Form 4 |
| 2026-07-06 | Camblong JurgiDirector, Executive Chairman | Saleplan | 22,486 | 5.26 | $118,276 | 3,558,807 | Form 4 |
| 2026-07-06 | Menu PhilippeChief Medical Officer | Saleplan | 7,393 | 5.16 | $38,148 | 233,387 | Form 4 |
| 2026-07-06 | Puylaert KevinChief Sales Officer | Sale | 138 | 5.03 | $694 | 148,026 | Form 4 |
| 2026-07-06 | Puylaert KevinChief Sales Officer | Sale | 47 | 5.03 | $236 | 147,979 | Form 4 |
| 2026-07-06 | Puylaert KevinChief Sales Officer | Sale | 31 | 5.09 | $158 | 147,948 | Form 4 |
| 2026-07-06 | Muken RossDirector, Chief Executive Officer | Saleplan | 9,838 | 5.22 | $51,354 | 670,651 | Form 4 |
| 2026-07-06 | Xu ZhenyuChief Scientific Officer | Saleplan | 7,393 | 5.17 | $38,222 | 614,887 | Form 4 |
| 2026-07-06 | Verma AbhimanyuChief Technology Officer | Saleplan | 5,285 | 5.10 | $26,953 | 192,171 | Form 4 |
| 2026-07-06 | Valente ManuelaChief People Officer | Saleplan | 4,241 | 5.05 | $21,417 | 210,450 | Form 4 |
| 2026-07-06 | Cardoza GeorgeChief Financial Officer | Saleplan | 1,592 | 5.29 | $8,422 | 309,092 | Form 4 |
| 2026-06-30 | Camblong JurgiDirector, Executive Chairman | Saleplan | 45,419 | 6.14 | $278,873 | 3,601,143 | Form 4 |
| 2026-06-30 | Camblong JurgiDirector, Executive Chairman | Saleplan | 19,650 | 6.02 | $118,293 | 3,581,493 | Form 4 |
| 2026-06-30 | Camblong JurgiDirector, Executive Chairman | Saleplan | 200 | 6.30 | $1,260 | 3,581,293 | Form 4 |
| 2026-06-29 | Camblong JurgiDirector, Executive Chairman | Saleplan | 18,060 | 5.87 | $106,012 | 3,601,493 | Form 4 |
| 2026-06-29 | Camblong JurgiDirector, Executive Chairman | Saleplan | 350 | 6.00 | $2,100 | 3,601,143 | Form 4 |
| 2026-06-26 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 18,129 | 5.73 | $103,879 | 3,601,493 | Form 4 |
| 2026-06-26 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 31,940 | 5.84 | $186,530 | 3,601,493 | Form 4 |
| 2026-06-25 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 1,373 | 5.70 | $7,826 | 3,619,622 | Form 4 |
| 2026-06-25 | Menu PhilippeChief Medical Officer | Saleplan | 5,000 | 5.50 | $27,500 | 240,780 | Form 4 |
| 2026-06-25 | Verma AbhimanyuChief Technology Officer | Saleplan | 6,944 | 5.51 | $38,261 | 197,456 | Form 4 |
| 2026-06-22 | Muken RossPresident | Saleplan | 422 | 5.38 | $2,270 | 680,489 | Form 4 |
| 2026-06-22 | Cardoza GeorgeChief Financial Officer | Saleplan | 774 | 5.38 | $4,164 | 310,684 | Form 4 |
| 2026-06-15 | Xu ZhenyuChief Scientific Officer | Saleplan | 4,000 | 5.01 | $20,040 | 622,280 | Form 4 |
| 2026-06-12 | Menu PhilippeChief Medical Officer | Saleplan | 5,000 | 4.95 | $24,750 | 245,780 | Form 4 |
| 2026-06-10 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 8,500 | 5.24 | $44,540 | 3,620,995 | Form 4 |
| 2026-06-05 | Cardoza GeorgeChief Financial Officer | Buy | 20,000 | 4.95 | $99,000 | 311,458 | Form 4 |
| 2026-05-26 | Menu PhilippeChief Medical Officer | Saleplan | 5,000 | 4.95 | $24,750 | 250,780 | Form 4 |
| 2026-05-19 | Puylaert KevinChief Sales Officer | Sale | 33 | 4.54 | $150 | 148,164 | Form 4 |
| 2026-05-19 | Valente ManuelaChief People Officer | Saleplan | 380 | 4.60 | $1,748 | 214,691 | Form 4 |
| 2026-05-19 | Van Well DaanChief Legal Officer | Saleplan | 684 | 4.60 | $3,146 | 345,052 | Form 4 |
| 2026-05-19 | Menu PhilippeChief Medical Officer | Saleplan | 608 | 4.61 | $2,803 | 255,780 | Form 4 |
| 2026-05-19 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 4,486 | 4.60 | $20,636 | 3,629,495 | Form 4 |
| 2026-05-19 | Xu ZhenyuChief Scientific Officer | Saleplan | 608 | 4.60 | $2,797 | 626,280 | Form 4 |
| 2026-05-19 | Muken RossPresident | Saleplan | 761 | 4.60 | $3,501 | 680,911 | Form 4 |
| 2026-05-13 | Xu ZhenyuChief Scientific Officer | Saleplan | 4,000 | 4.54 | $18,160 | 626,888 | Form 4 |
| 2026-05-12 | Menu PhilippeChief Medical Officer | Saleplan | 5,000 | 4.67 | $23,350 | 256,388 | Form 4 |
| 2026-05-12 | Hibbs Kathy LDirector | Saleplan | 7,508 | 4.67 | $35,062 | 89,768 | Form 4 |
| 2026-05-11 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 8,500 | 5.09 | $43,265 | 3,633,981 | Form 4 |
| 2026-04-27 | Menu PhilippeChief Medical Officer | Saleplan | 5,000 | 4.82 | $24,100 | 261,388 | Form 4 |
| 2026-04-20 | Puylaert KevinChief Sales Officer | Sale | 33 | 5.08 | $168 | 148,197 | Form 4 |
| 2026-04-20 | Muken RossPresident | Saleplan | 760 | 5.20 | $3,952 | 681,672 | Form 4 |
| 2026-04-20 | Menu PhilippeChief Medical Officer | Saleplan | 608 | 5.20 | $3,162 | 266,388 | Form 4 |
| 2026-04-20 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 4,486 | 5.21 | $23,372 | 3,642,481 | Form 4 |
| 2026-04-20 | Van Well DaanChief Legal Officer | Saleplan | 684 | 5.20 | $3,557 | 345,736 | Form 4 |
| 2026-04-20 | Xu ZhenyuChief Scientific Officer | Saleplan | 608 | 5.21 | $3,168 | 630,888 | Form 4 |
| 2026-04-20 | Valente ManuelaChief People Officer | Saleplan | 380 | 5.20 | $1,976 | 215,071 | Form 4 |
| 2026-04-15 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 17,473 | 5.00 | $87,365 | 3,646,967 | Form 4 |
| 2026-04-14 | Muken RossPresident | Saleplan | 2,800 | 4.96 | $13,888 | 682,432 | Form 4 |
| 2026-04-14 | Menu PhilippeChief Medical Officer | Saleplan | 1,600 | 4.96 | $7,936 | 266,996 | Form 4 |
| 2026-04-14 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 43,129 | 4.96 | $213,920 | 3,664,440 | Form 4 |
| 2026-04-14 | Xu ZhenyuChief Scientific Officer | Saleplan | 600 | 4.97 | $2,982 | 631,496 | Form 4 |
| 2026-04-13 | Menu PhilippeChief Medical Officer | Saleplan | 1,000 | 4.76 | $4,760 | 271,996 | Form 4 |
| 2026-04-13 | Menu PhilippeChief Medical Officer | Saleplan | 3,400 | 4.76 | $16,184 | 268,596 | Form 4 |
| 2026-04-13 | Muken RossPresident | Saleplan | 4,442 | 4.77 | $21,188 | 685,232 | Form 4 |
| 2026-04-13 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 4,399 | 4.76 | $20,939 | 3,707,569 | Form 4 |
| 2026-04-13 | Xu ZhenyuChief Scientific Officer | Saleplan | 1,014 | 4.76 | $4,827 | 635,496 | Form 4 |
| 2026-04-13 | Xu ZhenyuChief Scientific Officer | Saleplan | 3,400 | 4.76 | $16,184 | 632,096 | Form 4 |
| 2026-04-10 | Menu PhilippeChief Medical Officer | Saleplan | 3,725 | 4.68 | $17,433 | 272,996 | Form 4 |
| 2026-04-10 | Muken RossPresident | Saleplan | 3,687 | 4.69 | $17,292 | 689,674 | Form 4 |
| 2026-04-10 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 8,500 | 4.72 | $40,120 | 3,715,700 | Form 4 |
| 2026-04-10 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 3,732 | 4.72 | $17,615 | 3,711,968 | Form 4 |
| 2026-04-10 | Xu ZhenyuChief Scientific Officer | Saleplan | 3,706 | 4.68 | $17,344 | 636,510 | Form 4 |
| 2026-04-10 | Van Well DaanChief Legal Officer | Saleplan | 2,400 | 4.67 | $11,208 | 346,420 | Form 4 |
| 2026-04-09 | Van Well DaanChief Legal Officer | Saleplan | 1,988 | 4.74 | $9,423 | 348,820 | Form 4 |
| 2026-04-09 | Menu PhilippeChief Medical Officer | Saleplan | 1,931 | 4.74 | $9,153 | 276,721 | Form 4 |
| 2026-04-09 | Xu ZhenyuChief Scientific Officer | Saleplan | 1,936 | 4.74 | $9,177 | 640,216 | Form 4 |
| 2026-04-09 | Muken RossPresident | Saleplan | 1,950 | 4.74 | $9,243 | 693,361 | Form 4 |
| 2026-04-09 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 1,950 | 4.74 | $9,243 | 3,724,200 | Form 4 |
| 2026-04-08 | Cardoza GeorgeChief Financial Officer | Saleplan | 1,403 | 4.85 | $6,805 | 291,458 | Form 4 |
| 2026-04-08 | Van Well DaanChief Legal Officer | Saleplan | 2,861 | 4.85 | $13,876 | 350,808 | Form 4 |
| 2026-04-08 | Valente ManuelaChief People Officer | Saleplan | 3,824 | 4.85 | $18,546 | 215,451 | Form 4 |
| 2026-04-08 | Menu PhilippeChief Medical Officer | Saleplan | 2,800 | 4.84 | $13,552 | 278,652 | Form 4 |
| 2026-04-08 | Xu ZhenyuChief Scientific Officer | Saleplan | 2,800 | 4.84 | $13,552 | 642,152 | Form 4 |
| 2026-04-08 | Muken RossPresident | Saleplan | 2,786 | 4.84 | $13,484 | 695,311 | Form 4 |
| 2026-04-08 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 2,800 | 4.84 | $13,552 | 3,726,150 | Form 4 |
| 2026-04-07 | Verma AbhimanyuChief Technology Officer | Saleplan | 1,030 | 4.87 | $5,016 | 204,400 | Form 4 |
| 2026-04-07 | Xu ZhenyuChief Scientific Officer | Saleplan | 2,400 | 4.87 | $11,688 | 644,952 | Form 4 |
| 2026-04-07 | Valente ManuelaChief People Officer | Saleplan | 2,376 | 4.87 | $11,571 | 219,275 | Form 4 |
| 2026-04-07 | Cardoza GeorgeChief Financial Officer | Saleplan | 2,413 | 4.88 | $11,775 | 292,861 | Form 4 |
| 2026-04-07 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 2,500 | 4.86 | $12,150 | 3,728,950 | Form 4 |
| 2026-04-07 | Muken RossPresident | Saleplan | 2,424 | 4.87 | $11,805 | 698,097 | Form 4 |
| 2026-04-07 | Van Well DaanChief Legal Officer | Saleplan | 2,400 | 4.87 | $11,688 | 353,669 | Form 4 |
| 2026-04-07 | Menu PhilippeChief Medical Officer | Saleplan | 2,400 | 4.87 | $11,688 | 281,452 | Form 4 |
| 2026-04-06 | Verma AbhimanyuChief Technology Officer | Saleplan | 2,519 | 4.86 | $12,242 | 205,430 | Form 4 |
| 2026-04-06 | Xu ZhenyuChief Scientific Officer | Saleplan | 2,700 | 4.85 | $13,095 | 647,352 | Form 4 |
| 2026-04-06 | Valente ManuelaChief People Officer | Saleplan | 2,597 | 4.85 | $12,595 | 221,651 | Form 4 |
| 2026-04-06 | Cardoza GeorgeChief Financial Officer | Saleplan | 2,520 | 4.85 | $12,222 | 295,274 | Form 4 |
| 2026-04-06 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 2,600 | 4.85 | $12,610 | 3,731,450 | Form 4 |
| 2026-04-06 | Muken RossPresident | Saleplan | 2,600 | 4.85 | $12,610 | 700,521 | Form 4 |
| 2026-04-06 | Van Well DaanChief Legal Officer | Saleplan | 2,705 | 4.86 | $13,146 | 356,069 | Form 4 |
| 2026-04-06 | Puylaert KevinChief Sales Officer | Sale | 548 | 4.86 | $2,663 | 148,306 | Form 4 |
| 2026-04-06 | Puylaert KevinChief Sales Officer | Sale | 46 | 4.86 | $224 | 148,260 | Form 4 |
| 2026-04-06 | Puylaert KevinChief Sales Officer | Sale | 30 | 4.83 | $145 | 148,230 | Form 4 |
| 2026-04-06 | Menu PhilippeChief Medical Officer | Saleplan | 2,700 | 4.85 | $13,095 | 283,852 | Form 4 |
| 2026-03-31 | Puylaert KevinChief Sales Officer | Sale | 3 | 4.71 | $14 | 92,383 | Form 4 |
| 2026-03-19 | Cardoza GeorgeChief Financial Officer | Saleplan | 774 | 4.79 | $3,707 | 184,858 | Form 4 |
| 2026-03-19 | Puylaert KevinChief Sales Officer | Sale | 33 | 4.76 | $157 | 92,386 | Form 4 |
| 2026-03-19 | Muken RossPresident | Saleplan | 1,183 | 4.79 | $5,667 | 271,910 | Form 4 |
| 2026-03-19 | Valente ManuelaChief People Officer | Saleplan | 380 | 4.79 | $1,820 | 152,379 | Form 4 |
| 2026-03-19 | Xu ZhenyuChief Scientific Officer | Saleplan | 608 | 4.78 | $2,906 | 537,116 | Form 4 |
| 2026-03-19 | Menu PhilippeChief Medical Officer | Saleplan | 608 | 4.79 | $2,912 | 173,616 | Form 4 |
| 2026-03-19 | Camblong JurgiDirector, Chief Executive Officer | Saleplan | 4,486 | 4.77 | $21,398 | 3,302,839 | Form 4 |
| 2026-03-19 | Van Well DaanChief Legal Officer | Saleplan | 684 | 4.79 | $3,276 | 261,238 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
14 × grant or award7 × option exercise
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-19 | Valente ManuelaChief People Officer | Option exercise M | +10,000 | 3.20 | 220,450 | Form 4 |
| 2026-08-07 | Xu ZhenyuChief Scientific Officer | Option exercise M | +7,000 | 3.28 | 607,887 | Form 4 |
| 2026-08-05 | Xu ZhenyuChief Scientific Officer | Option exercise M | +3,000 | 3.28 | 603,887 | Form 4 |
| 2026-07-20 | Camblong JurgiDirector, Executive Chairman | Option exercise M | +4,581 | 3.16 | 3,517,403 | Form 4 |
| 2026-06-30 | Camblong JurgiDirector, Executive Chairman | Option exercise M | +45,419 | 3.16 | 3,646,562 | Form 4 |
| 2026-06-29 | Camblong JurgiDirector, Executive Chairman | Option exercise M | +18,060 | 3.16 | 3,619,553 | Form 4 |
| 2026-06-26 | Camblong JurgiDirector, Chief Executive Officer | Option exercise M | +31,940 | 3.16 | 3,633,433 | Form 4 |
| 2026-06-18 | Hirsch DidierDirector | Grant or award A | +19,724 | 5.46 | 240,220 | Form 4 |
| 2026-06-18 | Cossery Jean-MichelDirector | Grant or award A | +19,724 | 5.46 | 206,212 | Form 4 |
| 2026-06-18 | Ossipow VincentDirector | Grant or award A | +19,724 | 5.46 | 522,860 | Form 4 |
| 2026-06-18 | Hibbs Kathy LDirector | Grant or award A | +19,724 | 5.46 | 109,492 | Form 4 |
| 2026-06-18 | Cox TroyDirector | Grant or award A | +19,724 | 5.46 | 328,743 | Form 4 |
| 2026-04-02 | Verma AbhimanyuChief Technology Officer | Grant or award A | +82,136 | – | 207,949 | Form 4/A |
| 2026-04-02 | Xu ZhenyuChief Scientific Officer | Grant or award A | +112,936 | – | 650,052 | Form 4/A |
| 2026-04-02 | Valente ManuelaChief People Officer | Grant or award A | +71,869 | – | 224,248 | Form 4/A |
| 2026-04-02 | Puylaert KevinChief Sales Officer | Grant or award A | +56,468 | – | 148,854 | Form 4/A |
| 2026-04-02 | Menu PhilippeChief Medical Officer | Grant or award A | +112,936 | – | 286,552 | Form 4/A |
| 2026-04-02 | Camblong JurgiDirector, Chief Executive Officer | Grant or award A | +431,211 | – | 3,734,050 | Form 4/A |
| 2026-04-02 | Cardoza GeorgeChief Financial Officer | Grant or award A | +112,936 | – | 297,794 | Form 4/A |
| 2026-04-02 | Muken RossPresident | Grant or award A | +431,211 | – | 703,121 | Form 4/A |
| 2026-04-02 | Van Well DaanChief Legal Officer | Grant or award A | +97,536 | – | 358,774 | Form 4/A |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.